Last reviewed · How we verify

NCT05745519

Discussion on Pulse Diagnosis and Heart Rhythm Variability of Patients With Chronic Insomnia

Completed Last updated 27 February 2023
What this trial tests

trial testing Pittsburgh sleep quality index (PSQI) in Heart Rate Variability in 72 participants. Completed in 31 December 2022.

Timeline
1 January 2022
Primary endpoint
1 December 2022
31 December 2022

Quick facts

Lead sponsorNational Cheng-Kung University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment72
Start date1 January 2022
Primary completion1 December 2022
Estimated completion31 December 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Cheng-Kung University Hospital

Who can join

Adults 40 to 79, any sex, with Heart Rate Variability or Insomnia Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Discuss the objective assessment of patients with insomnia by pulse diagnosis, and measure by subjective questionnaire and physiological instruments.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Advances and prospects of mucosal vaccination in the prevention and control of avian influenza.
    Hui X, Tian X, Ding S, Gao G, et al · · 2026 · PMID 41727464 · DOI 10.3389/fimmu.2026.1766957

Verify or expand the search:

Other recruiting trials for Heart Rate Variability

Currently open trials in the same condition.

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05745519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing